Zi-Wei Ren

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A series of hybrids derived from 4-anilinoquinazoline and hydroxamic acid were designed, synthesized, and evaluated as dual inhibitors of vascular endothelia growth factor receptor-2 (VEGFR-2) tyrosine kinase and histone deacetylase (HDAC). Most of these compounds exhibited potent HDAC inhibition and moderate VEGFR-2 inhibition. Among them, compound 6l(More)
  • Fan-Wei Peng, Ji Xuan, +8 authors Lei Shi
  • European journal of medicinal chemistry
  • 2016
A single agent that simultaneously inhibits multiple targets may offer greater therapeutic benefits in cancer than single-acting agents through interference with multiple pathways and potential synergistic action. In this work, a series of hybrids bearing N-phenylquinazolin-4-amine and hydroxamic acid moieties were designed and identified as dual(More)
  • 1